流動資産 変化する 日付
AbbVie USD 37.48B 3.81B 2026-09
Alnylam Pharmaceuticals USD 5.11B 492.49M 2026-09
Amgen USD 34.36B 598M 2026-09
Arrowhead Research USD 1.67B 168.34M 2026-06
AstraZeneca USD 31.45B 3.48B 2026-09
Biogen USD 7.58B 278.7M 2026-09
Bristol-Myers Squibb USD 29.77B 1.19B 2026-09
Cytokinetics USD 1.19B 21.34M 2026-09
GlaxoSmithKline GBP 17.9B 336M 2026-09
J&J USD 56.35B 3.42B 2026-09
Karyopharm Therapeutics USD 126.33M 23.19M 2026-03
MacroGenics USD 321.69M 139.16M 2026-06
Merck USD 38.94B 2.26B 2026-09
Novartis USD 28.75B 1.4B 2026-09
Pfizer USD 45.01B 3.65B 2026-09
Regeneron Pharmaceuticals USD 20.8B 2.35B 2026-09
Roche Holding CHF 35.44B 3.29B 2026-06
Xencor USD 498.66M 24.55M 2026-09